J. Goldman & CO LP Catalyst Biosciences, Inc. Transaction History

J. Goldman & CO LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $55,287 - $252,740	-60,755 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $229,653 - $314,710	60,755 New	60,755 $250,000
Q2 2020 Aug 14, 2020	SELL	$3.76 - $8.01 $1.23 Million - $2.61 Million	-326,008 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $1.14 Million - $2.77 Million	326,008 New	326,008 $1.43 Million
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $4,675 - $6,220	-500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $1.65 Million - $5.23 Million	-181,047 Reduced 99.72%	500 $6,000
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $808,926 - $2.03 Million	57,047 Added 45.82%	181,547 $4.68 Million
Q4 2017 Feb 14, 2018	BUY	$4.52 - $13.69 $562,740 - $1.7 Million	124,500	124,500 $1.7 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.